News Snapshot:
Fosun and BioNTech jointly begin phase I clinical test of mRNA-based COVID-19 vaccine in China Fosun and BioNTech jointly begin phase I clinical test of mRNA-based COVID-19 vaccine in China Pineville Staff Writer | September 6, 2020 | Vaccine Photo:Xinhua Shanghai-based pharmaceutical company Fosun Pharma and Germany-based BioNTech SE jointly announced on Wednesday that they have began phase I clinical tests of mRNA-based COVID-19 vaccine in China. The first 72 participants have been dosed with BNT162b1. The phase 1 clinical trial in China will enroll 144 healthy individuals in total, so as to evaluate the safety and immunogenicity of the...
